Stryker Corporation (SYK)
Quick ratio
| Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | US$ in thousands | 4,011,000 | 3,256,000 | 2,375,000 | 2,320,000 | 3,652,000 | 3,850,000 | 1,874,000 | 2,330,000 | 2,971,000 | 1,860,000 | 1,401,000 | 1,671,000 | 1,844,000 | 1,420,000 | 1,044,000 | 1,458,000 | 2,944,000 | 2,563,000 | 2,241,000 | 2,238,000 |
| Short-term investments | US$ in thousands | 89,000 | 87,000 | 89,000 | 89,000 | 841,000 | 834,000 | 83,000 | 77,000 | 82,000 | 76,000 | 77,000 | 86,000 | 84,000 | 77,000 | 83,000 | 72,000 | 75,000 | 76,000 | 84,000 | 74,000 |
| Receivables | US$ in thousands | 4,039,000 | 3,643,000 | 3,918,000 | 3,961,000 | 3,987,000 | 3,736,000 | 3,622,000 | 3,473,000 | 3,765,000 | 3,276,000 | 3,261,000 | 3,215,000 | 3,565,000 | 3,103,000 | 3,145,000 | 2,991,000 | 3,022,000 | 2,817,000 | 2,714,000 | 2,616,000 |
| Total current liabilities | US$ in thousands | 7,794,000 | 7,414,000 | 7,288,000 | 7,929,000 | 7,616,000 | 7,669,000 | 6,926,000 | 6,955,000 | 7,921,000 | 7,458,000 | 6,584,000 | 5,866,000 | 6,303,000 | 4,571,000 | 4,404,000 | 4,408,000 | 4,549,000 | 4,449,000 | 4,252,000 | 3,953,000 |
| Quick ratio | 1.04 | 0.94 | 0.88 | 0.80 | 1.11 | 1.10 | 0.81 | 0.85 | 0.86 | 0.70 | 0.72 | 0.85 | 0.87 | 1.01 | 0.97 | 1.03 | 1.33 | 1.23 | 1.19 | 1.25 |
December 31, 2025 calculation
Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($4,011,000K
+ $89,000K
+ $4,039,000K)
÷ $7,794,000K
= 1.04
Peer comparison
Dec 31, 2025
Company name
Symbol
Quick ratio
Stryker Corporation
SYK
1.04
Abbott Laboratories
ABT
1.24
CONMED Corporation
CNMD
0.84